Effects of Mobile Medicine on Cancer Patients

Not Applicable

• Conditions: Cancer Pain
• Interventions: Behavioral: mini program; Behavioral: conventional pharmaceutical care

• Registration Number: NCT05049811
• Lead Sponsor: Fujian Cancer Hospital

Brief Summary

With the existing medical system and insufficient medical resources in China, we developed a mini program. a pain management mini app can be useful and appreciated by patients and health care professionals, making it a good choice for the management of cancer pain in our country . our study want to develop and test the mini program for pain management among Chinese cancer patients in or discharged from hospital treatment.

Detailed Description

Healthcare interventions delivered via personal mobile device have been shown to be acceptable to users, who have identified benefits such as convenience, access to personalized information, greater awareness of own health. Integrating mini program into the cancer pain care may be an effective strategy to improve cancer pain patients self-management.

To design, construct, and test the mini program in patients managing cancer pain, evaluate the total remission rate of pain and the improvement in medicine compliance to improve pain management for cancer pain patients, and assess patient acceptance of the mini program.

Study Timeline

• Status Verified: 2021-09
• Study First Submitted: 2021-09-09
• Study First Submitted QC: 2021-09-09
• Last Update Submitted: 2021-09-17
• Study First Posted: 2021-09-20
• Last Update Posted: 2021-09-21
• Study Start: 2021-11
• Primary Completion: 2022-05
• Study Completion: 2022-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients aged 18 years or older;
• Be able to read Chinese and use a mobile phone;
• Histologically or cytologically confirmed solid tumor;
• Diagnosed chronic cancer pain
• Could understand the study process and evaluation, agreed to participate in the trial, and signed the informed consent form.

Read More

Exclusion Criteria

• Illiterate person;
• Incompetence;
• Inability to complete the pain assessment;
• Participation in any other therapies or other study protocols that may have an impact on pain intensity, which were the main outcomes of this study.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
a mini program trial group	mini program	Pharmacists conducted a standardized education session to teach the participants how to operate the mobile phone, use mini program, assess pain. The participants in the trial group were asked to complete initial and final pain assessment questionnaires and Medication compliance on the mobile phones provided to them. Participants were encouraged to use mini program as much as possible to record their pain status.
a control group	conventional pharmaceutical care	The control group received conventional pharmaceutical care. Initial and final pain and Medication compliance data were collected. Before the patient was discharged from the hospital, the clinical pharmacist conducted detailed medication education (including medication methods, prevention and treatment of adverse reactions, and precautions) and asked the patient to attempt to maintain a paper version of the pain diary.

Primary Outcome Measures

Name	Time	Method
Change in pain score	Change from baseline at four weeks after discharge	Comparison of pain score of cancer pain patients with or without mini program. Pain score will be assessed by using numeric rating scale (NRS). An NRS allows a person to describe the intensity of his/her pain as a number usually ranging from 0 to 10, where "0" means "no pain" and "10" means pain as "bad as it could be."

Secondary Outcome Measures

Name	Time	Method
Incidence of adverse events	Up to four weeks after discharge	Adverse events will be assessed throughout the study according the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Event (CTCAE) Version 4.0. Number of subjects who experienced an adverse event in this study is presented.
Change in medication adherence	Change from baseline at four weeks after discharge	The investigators will measure the change in medication adherence via Morisky Scale. Morisky Scale contains 4 questions, and the total score ranges from 0 to 4 with lower scores indicating higher adherence.
Change in quality of life	Change from baseline at four weeks after discharge	Comparison of quality of life of cancer pain patients with or without mini program. Quality of life is assessed using EuroQol- 5 Dimension (EQ-5D).